- Home
- ORIC vs IRS Comparison
ORIC vs IRS Comparison
Compare ORIC & IRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- IRS
- Stock Information
- Founded
- ORIC 2014
- IRS 1943
- Country
- ORIC United States
- IRS Argentina
- Employees
- ORIC N/A
- IRS N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- IRS Homebuilding
- Sector
- ORIC Health Care
- IRS Real Estate
- Exchange
- ORIC Nasdaq
- IRS Nasdaq
- Market Cap
- ORIC 1.1B
- IRS 1.2B
- IPO Year
- ORIC 2020
- IRS 1994
- Fundamental
- Price
- ORIC $12.20
- IRS $15.86
- Analyst Decision
- ORIC Strong Buy
- IRS
- Analyst Count
- ORIC 8
- IRS 0
- Target Price
- ORIC $17.86
- IRS N/A
- AVG Volume (30 Days)
- ORIC 1.1M
- IRS 302.7K
- Earning Date
- ORIC 11-13-2025
- IRS 11-06-2025
- Dividend Yield
- ORIC N/A
- IRS 6.25%
- EPS Growth
- ORIC N/A
- IRS N/A
- EPS
- ORIC N/A
- IRS 0.42
- Revenue
- ORIC N/A
- IRS $370,153,377.00
- Revenue This Year
- ORIC N/A
- IRS N/A
- Revenue Next Year
- ORIC N/A
- IRS N/A
- P/E Ratio
- ORIC N/A
- IRS $3.38
- Revenue Growth
- ORIC N/A
- IRS 41.49
- 52 Week Low
- ORIC $3.90
- IRS $10.61
- 52 Week High
- ORIC $14.93
- IRS $17.67
- Technical
- Relative Strength Index (RSI)
- ORIC 46.07
- IRS 66.47
- Support Level
- ORIC $12.02
- IRS $15.00
- Resistance Level
- ORIC $13.04
- IRS $16.11
- Average True Range (ATR)
- ORIC 0.75
- IRS 0.80
- MACD
- ORIC -0.12
- IRS 0.12
- Stochastic Oscillator
- ORIC 20.69
- IRS 87.62
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About IRS IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)
IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segments include Shopping Malls, which comprise lease and service revenues principally related to the rental of commercial and other spaces in the company's shopping malls; Offices, which include lease revenues and other service revenues related to office activities; Sales and Developments, which include the development, maintenance, and sales of undeveloped parcels of land and/or trading properties; Hotels, which mainly include revenues from rooms, catering, and restaurants; and others. The company generates the majority of its revenue from the Shopping Malls segment.